Cargando…
Current status of Cancer Nanotheranostics: Emerging strategies for cancer management
Cancer diagnosis and management have been a slow-evolving area in medical science. Conventional therapies have by far proved to have various limitations. Also, the concept of immunotherapy which was thought to revolutionize the management of cancer has presented its range of drawbacks. To overcome t...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161386/ https://www.ncbi.nlm.nih.gov/pubmed/37151802 http://dx.doi.org/10.7150/ntno.82263 |
_version_ | 1785037484284968960 |
---|---|
author | Chavda, Vivek P Khadela, Avinash Shah, Yasha Postwala, Humzah Balar, Pankti Vora, Lalit |
author_facet | Chavda, Vivek P Khadela, Avinash Shah, Yasha Postwala, Humzah Balar, Pankti Vora, Lalit |
author_sort | Chavda, Vivek P |
collection | PubMed |
description | Cancer diagnosis and management have been a slow-evolving area in medical science. Conventional therapies have by far proved to have various limitations. Also, the concept of immunotherapy which was thought to revolutionize the management of cancer has presented its range of drawbacks. To overcome these limitations nanoparticulate-derived diagnostic and therapeutic strategies are emerging. These nanomaterials are to be explored as they serve as a prospect for cancer theranostics. Nanoparticles have a significant yet unclear role in screening as well as therapy of cancer. However, nanogels and Photodynamic therapy is one such approach to be developed in cancer theranostics. Photoactive cancer theranostics is a vivid area that might prove to help manage cancer. Also, the utilization of the quantum dots as a diagnostic tool and to selectively kill cancer cells, especially in CNS tumors. Additionally, the redox-sensitive micelles targeting the tumor microenvironment of the cancer are also an important theranostic tool. This review focuses on exploring various agents that are currently being studied or can further be studied as cancer theranostics. |
format | Online Article Text |
id | pubmed-10161386 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-101613862023-05-06 Current status of Cancer Nanotheranostics: Emerging strategies for cancer management Chavda, Vivek P Khadela, Avinash Shah, Yasha Postwala, Humzah Balar, Pankti Vora, Lalit Nanotheranostics Review Cancer diagnosis and management have been a slow-evolving area in medical science. Conventional therapies have by far proved to have various limitations. Also, the concept of immunotherapy which was thought to revolutionize the management of cancer has presented its range of drawbacks. To overcome these limitations nanoparticulate-derived diagnostic and therapeutic strategies are emerging. These nanomaterials are to be explored as they serve as a prospect for cancer theranostics. Nanoparticles have a significant yet unclear role in screening as well as therapy of cancer. However, nanogels and Photodynamic therapy is one such approach to be developed in cancer theranostics. Photoactive cancer theranostics is a vivid area that might prove to help manage cancer. Also, the utilization of the quantum dots as a diagnostic tool and to selectively kill cancer cells, especially in CNS tumors. Additionally, the redox-sensitive micelles targeting the tumor microenvironment of the cancer are also an important theranostic tool. This review focuses on exploring various agents that are currently being studied or can further be studied as cancer theranostics. Ivyspring International Publisher 2023-05-01 /pmc/articles/PMC10161386/ /pubmed/37151802 http://dx.doi.org/10.7150/ntno.82263 Text en © The author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
spellingShingle | Review Chavda, Vivek P Khadela, Avinash Shah, Yasha Postwala, Humzah Balar, Pankti Vora, Lalit Current status of Cancer Nanotheranostics: Emerging strategies for cancer management |
title | Current status of Cancer Nanotheranostics: Emerging strategies for cancer management |
title_full | Current status of Cancer Nanotheranostics: Emerging strategies for cancer management |
title_fullStr | Current status of Cancer Nanotheranostics: Emerging strategies for cancer management |
title_full_unstemmed | Current status of Cancer Nanotheranostics: Emerging strategies for cancer management |
title_short | Current status of Cancer Nanotheranostics: Emerging strategies for cancer management |
title_sort | current status of cancer nanotheranostics: emerging strategies for cancer management |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161386/ https://www.ncbi.nlm.nih.gov/pubmed/37151802 http://dx.doi.org/10.7150/ntno.82263 |
work_keys_str_mv | AT chavdavivekp currentstatusofcancernanotheranosticsemergingstrategiesforcancermanagement AT khadelaavinash currentstatusofcancernanotheranosticsemergingstrategiesforcancermanagement AT shahyasha currentstatusofcancernanotheranosticsemergingstrategiesforcancermanagement AT postwalahumzah currentstatusofcancernanotheranosticsemergingstrategiesforcancermanagement AT balarpankti currentstatusofcancernanotheranosticsemergingstrategiesforcancermanagement AT voralalit currentstatusofcancernanotheranosticsemergingstrategiesforcancermanagement |